BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile
..
 

Prism Pharmaceuticals, Inc. 



Danbury  Connecticut    U.S.A.
Phone: n/a Fax:


SEARCH JOBS


Industry
Pharmaceutical






 Company News
Baxter International, Inc. (BAX) to Acquire Prism Pharmaceuticals, Inc. for $338 Million 4/19/2011 7:43:35 AM    More...
Prism Pharmaceuticals, Inc. Receives FDA Approval of Ready-to-Use NEXTERONE(R) (amiodarone HCl) Premixed Injection 11/18/2010 7:11:41 AM    More...
CyDex Pharmaceuticals Obtains Full Development and Commercialization Rights to Novel Captisol-Enabled(R) Intravenous Formulation of Clopidogrel; Terminating Agreement with Prism Pharmaceuticals, Inc. 10/12/2010 7:37:22 AM    More...
Prism Pharmaceuticals, Inc.'s Study of Injectable Clopidogrel Accepted for Presentation at the American College of Cardiology 2/9/2009 10:54:45 AM    More...
Prism Pharmaceuticals, Inc. to Receive $10 Million Milestone Payment from Paul Capital Healthcare 1/8/2009 7:38:44 AM    More...
CyDex Pharmaceuticals Announces CAPTISOL(R) Technology Used in Recently Approved Cosolvent-Free Formulation of Amiodarone IV 1/5/2009 9:41:18 AM    More...
Prism Pharmaceuticals, Inc. Receives FDA Approval of NEXTERONE(R) for Life-Threatening Ventricular Fibrillation and Ventricular Tachycardia 1/5/2009 7:17:04 AM    More...
Prism Pharmaceuticals, Inc. Appoints Maurits Geerlings Vice President of Business Development 10/3/2007 7:35:59 AM    More...
Prism Pharmaceuticals, Inc. Raises $68 Million To Advance Acute Care Portfolio 9/18/2006 1:31:36 PM    More...
Hollister-Stier Laboratories Contract Manufacturing Signs Agreement With Prism Pharmaceuticals, Inc. 4/4/2006 12:29:02 PM    More...
12

//-->